Li, K., Wang, F., & Hu, Z. (2017). Targeting pseudokinase TRIB3 brings about a new therapeutic option for acute promyelocytic leukemia. Mol Cell Oncol.
Citação norma ChicagoLi, Ke, Feng Wang, and Zhuo-Wei Hu. "Targeting Pseudokinase TRIB3 Brings About a New Therapeutic Option for Acute Promyelocytic Leukemia." Mol Cell Oncol 2017.
Citação norma MLALi, Ke, Feng Wang, and Zhuo-Wei Hu. "Targeting Pseudokinase TRIB3 Brings About a New Therapeutic Option for Acute Promyelocytic Leukemia." Mol Cell Oncol 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.